We bring you the latest news from the healthcare about the health care in the United Kingdom.

maandag 30 april 2018

Signal Transduction and Targeted Therapy - April 2018

Signal Transduction and Targeted Therapy

Table of Contents: April 2018

Brief Communication | 27 April 2018

Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting S. typhimurium A1-R is superior to first-line chemotherapy

Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Kei Kawaguchi, Sang Nam Yoon et al.

Signal Transduction and Targeted Therapy 3 , Article number: 12 |  doi: 10.1038/s41392-018-0016-7

Review Article | 20 April 2018

Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival

Enrique Rozengurt, James Sinnett-Smith & Guido Eibl

Signal Transduction and Targeted Therapy 3 , Article number: 11 |  doi: 10.1038/s41392-017-0005-2

Author Correction | 19 April 2018

Author Correction: Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis

Aung Than, Shaohai Xu, Ru Li, Melvin Khee-Shing Leow, Lei Sun et al.

Signal Transduction and Targeted Therapy 3 , Article number: 10 |  doi: 10.1038/s41392-018-0014-9

Article | 13 April 2018

Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models

Nicholas L. Syn, Pei Li Lim, Li Ren Kong, Lingzhi Wang, Andrea Li-Ann Wong et al.

Signal Transduction and Targeted Therapy 3 , Article number: 9 |  doi: 10.1038/s41392-018-0010-0

Your email address is in the Signal Transduction and Targeted Therapy mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature